Online

Detectes differentially methylated genes based on a Bayesian framework. The DM-BLD approach features a joint model to capture both the local dependency of measured loci and the dependency of methylation changes in samples. Specifically, the local dependency is modeled by Leroux conditional autoregressive structure; the dependency of methylation changes is modeled by a discrete Markov random field. A hierarchical Bayesian model is developed to fully take into account the local dependency for differential analysis, in which differential states are embedded as hidden variables.

User report

×
Vote up tools and offer feedback
Give value to tools and make your expertise visible

0 user reviews

0 user reviews

No review has been posted.

DM-BLD forum

×
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.

No open topic.

DM-BLD versioning

×
Upload and version your source code
Get your DOI for better tool traceability. Archive your releases so the community can easily visualize progress on you work.

No versioning.

DM-BLD classification

DM-BLD specifications

Software type:
Package/Module
Restrictions to use:
None
Programming languages:
MATLAB
Version:
2.0
Maintained:
Yes
Interface:
Command line interface
Operating system:
Unix/Linux, Mac OS, Windows
Computer skills:
Advanced
Stability:
Stable

DM-BLD support

Documentation

Maintainer

  • Jianhua Xuan <>

Credits

×
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.

Publications

Institution(s)

Bradley Department of Electrical and Computer Engineering, Virginia Polytechnic Institute and State University, Arlington, VA, USA; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, WA, DC, USA

Funding source(s)

This work was supported in part by the National Institutes of Health (CA149653, CA149147, CA184902, CA164384).

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.